O36.822
Fetal anemia and thrombocytopenia, second trimester
Clinical Classification Guidelines
Medical Intelligence & Overview
Fetal anemia and thrombocytopenia are conditions affecting a developing fetus during pregnancy, particularly noticeable during the second trimester. Fetal anemia refers to a deficiency of healthy red blood cells in the fetus, which can impair oxygen delivery. Thrombocytopenia denotes a lower-than-normal platelet count, affecting blood clotting. These conditions can result from various underlying causes and may pose risks to both the fetus and the pregnancy if not properly managed. Monitoring and intervention are key components of managing these conditions, especially during the critical developmental period of the second trimester.
Causes & Symptoms
Clinical Causes: Rh incompatibility between mother and fetus Maternal infections such as parvovirus B19 or cytomegalovirus (CMV) Fetal genetic disorders affecting blood cell production Fetal bleeding due to placental abruption or vascular malformations Maternal autoimmune diseases like lupus that can affect placental blood flow Placental insufficiency or abnormalities disrupting nutrient and oxygen transfer Maternal drug or medication exposure impacting fetal bone marrow function
Key Symptoms: No direct symptoms are usually observable in the fetus; detection occurs during prenatal testing Ultrasound findings, such as fetal hydrops (accumulation of fluid in fetal compartments) Abnormal fetal heart rate patterns indicating distress Hydramnios or excess amniotic fluid due to fetal anemia In cases of severe fetal bleeding, there might be signs of fetal hypoxia
Diagnostic & Treatment
Diagnosis Path: Diagnosis of fetal anemia and thrombocytopenia involves a combination of prenatal tests, including: - **Ultrasound examinations** observing for signs of fetal hydrops and abnormal blood flow - **Middle cerebral artery (MCA) Doppler studies** assessing blood flow velocities indicative of anemia - **Amniocentesis** to analyze amniotic fluid for genetic and biochemical markers - **Percutaneous umbilical blood sampling (PUBS)** for direct measurement of fetal blood counts - **Maternal blood tests** to identify infections or autoimmune conditions that might affect the fetus Timely detection helps in planning appropriate interventions, potentially improving outcomes.
Treatment Protocols: Managing fetal anemia and thrombocytopenia may involve several approaches, depending on the severity and underlying cause: - **Intrauterine transfusions**: Direct transfusions into the fetal circulation to restore healthy red blood cell levels - **Treatment of maternal conditions**: Managing infections, autoimmune diseases, or other maternal health issues - **Monitoring fetal well-being closely** with regular ultrasounds and blood flow studies - **Delivery planning**: Early delivery may be necessary if fetal health is compromised, often via cesarean section - **Postnatal care**: After birth, infants may require transfusions or treatments for ongoing blood cell deficiencies Collaborative care involving specialists such as maternal-fetal medicine specialists, pediatric hematologists, and neonatologists is vital to optimize outcomes.
Clinical Advice & FAQs
Billing Guidance
Is O36.822 a billable ICD-10 code?
Yes, O36.822 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report O36.822?
Clinical documentation must specify the nature of Fetal anemia and thrombocytopenia, second trimester and any associated comorbidities for accurate reporting.
Cite this Clinical Reference